evidencegaps
Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

4,756 questions · 13,493 findings · 1,305 reviews · Headline outcomes only

Sort:Best matchNewestHighest certaintyDownload CSV
No studies found 2,594 · 19.2%GRADE not reported 728 · 5.4%Very low 2,868 · 21.3%Low 3,777 · 28%Moderate 2,620 · 19.4%High 906 · 6.7%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Oral miltefosine (50 mg for 28 days) vs 28 days on/off placebo regimen

Adverse effects (number of participants who had the event) · People with American cutaneous and mucocutaneous leishmaniasis

Oral miltefosine (50 mg for 28 days) probably leads to higher adverse effects (number of participants who had the event) compared with placebo (same regimen) (moderate certainty).

1 finding from 1 review

Botulinum toxin type A vs placebo

Adverse events (reported at any time) (2 RCT, 169 participants) · adults with blepharospasm

Botulinum toxin type A showed no clear difference in adverse events (reported at any time) (2 RCT, 169 participants) compared with placebo (low certainty).

1 finding from 1 review

Botulinum toxin type A vs placebo

Tolerability (number of dropouts; reported at any time) (2 RCT, 169 participants) · adults with blepharospasm

Botulinum toxin type A showed no clear difference in tolerability (number of dropouts; reported at any time) (2 RCT, 169… compared with placebo (moderate certainty).

1 finding from 1 review

NSAIDs vs placebo

Relief of pain · women who have given birth vaginally, requiring analgesia for after‐birth pains.

NSAID probably leads to higher adequate pain relief as reported by the woman (5 to 8 hours) compared with placebo (moderate certainty).

1 finding from 1 review

Opioids vs placebo

Relief of pain · women who have given birth vaginally, requiring analgesia for after‐birth pains.

Opioid showed no clear difference in adequate pain relief as reported by the woman (5 to 8 hours) compared with placebo (low certainty).

1 finding from 1 review

Opioids vs placebo

Need for additional pain relief (6 to 8 hours) · women who have given birth vaginally, requiring analgesia for after‐birth pains.

Opioid may leads to lower need for additional pain relief (6 to 8 hours) compared with placebo (low certainty).

1 finding from 1 review

Opioids vs placebo

Maternal adverse events (6 to 8 hours) · women who have given birth vaginally, requiring analgesia for after‐birth pains.

Opioid showed no clear difference in maternal adverse events (6 to 8 hours) compared with placebo (low certainty).

1 finding from 1 review

NSAIDs vs placebo

Additional pain relief · women who have given birth vaginally, requiring analgesia for after‐birth pains.

NSAID may leads to lower need for additional pain relief (5 to 8 hours) compared with placebo (low certainty).

1 finding from 1 review

Paracetamol vs placebo

Relief of pain · women who have given birth vaginally, requiring analgesia for after‐birth pains.

It is very uncertain whether paracetamol changes adequate pain relief as reported by the woman (6 hours) compared with placebo (very low certainty).

1 finding from 1 review

Paracetamol vs placebo

Need for additional pain relief (up to 4 hours) · women who have given birth vaginally, requiring analgesia for after‐birth pains.

It is very uncertain whether paracetamol changes need for additional pain relief (up to 4 hours) compared with placebo (very low certainty).

1 finding from 1 review